Cargando…

In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception

BACKGROUND: The need for woman-controlled, cheap, safe, effective, easy-to-use and easy-to-store topical applications for prophylaxis against sexually transmitted infections (STIs) makes surfactant-containing formulations an interesting option that requires a more fundamental knowledge concerning su...

Descripción completa

Detalles Bibliográficos
Autores principales: Inácio, Ângela S., Mesquita, Katia A., Baptista, Marta, Ramalho-Santos, João, Vaz, Winchil L. C., Vieira, Otília V.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095630/
https://www.ncbi.nlm.nih.gov/pubmed/21603626
http://dx.doi.org/10.1371/journal.pone.0019850
_version_ 1782203678069882880
author Inácio, Ângela S.
Mesquita, Katia A.
Baptista, Marta
Ramalho-Santos, João
Vaz, Winchil L. C.
Vieira, Otília V.
author_facet Inácio, Ângela S.
Mesquita, Katia A.
Baptista, Marta
Ramalho-Santos, João
Vaz, Winchil L. C.
Vieira, Otília V.
author_sort Inácio, Ângela S.
collection PubMed
description BACKGROUND: The need for woman-controlled, cheap, safe, effective, easy-to-use and easy-to-store topical applications for prophylaxis against sexually transmitted infections (STIs) makes surfactant-containing formulations an interesting option that requires a more fundamental knowledge concerning surfactant toxicology and structure-activity relationships. METHODOLOGY/PRINCIPAL FINDINGS: We report in vitro effects of surfactant concentration, exposure time and structure on the viability of mammalian cell types typically encountered in the vagina, namely, fully polarized and confluent epithelial cells, confluent but non-polarized epithelial-like cells, dendritic cells, and human sperm. Representatives of the different families of commercially available surfactants – nonionic (Triton X-100 and monolaurin), zwitterionic (DDPS), anionic (SDS), and cationic (C(n)TAB (n = 10 to 16), C(12)PB, and C(12)BZK) – were examined. Triton X-100, monolaurin, DDPS and SDS were toxic to all cell types at concentrations around their critical micelle concentration (CMC) suggesting a non-selective mode of action involving cell membrane destabilization and/or destruction. All cationic surfactants were toxic at concentrations far below their CMC and showed significant differences in their toxicity toward polarized as compared with non-polarized cells. Their toxicity was also dependent on the chemical nature of the polar head group. Our results suggest an intracellular locus of action for cationic surfactants and show that their structure-activity relationships could be profitably exploited for STI prophylaxis in vaginal gel formulations. The therapeutic indices comparing polarized epithelial cell toxicity to sperm toxicity for all surfactants examined, except C(12)PB and C(12)BZK, does not justify their use as contraceptive agents. C(12)PB and C(12)BZK are shown to have a narrow therapeutic index recommending caution in their use in contraceptive formulations. CONCLUSIONS/SIGNIFICANCE: Our results contribute to understanding the mechanisms involved in surfactant toxicity, have a predictive value with regard to their safety, and may be used to design more effective and less harmful surfactants for use in topical applications for STI prophylaxis.
format Text
id pubmed-3095630
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30956302011-05-19 In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception Inácio, Ângela S. Mesquita, Katia A. Baptista, Marta Ramalho-Santos, João Vaz, Winchil L. C. Vieira, Otília V. PLoS One Research Article BACKGROUND: The need for woman-controlled, cheap, safe, effective, easy-to-use and easy-to-store topical applications for prophylaxis against sexually transmitted infections (STIs) makes surfactant-containing formulations an interesting option that requires a more fundamental knowledge concerning surfactant toxicology and structure-activity relationships. METHODOLOGY/PRINCIPAL FINDINGS: We report in vitro effects of surfactant concentration, exposure time and structure on the viability of mammalian cell types typically encountered in the vagina, namely, fully polarized and confluent epithelial cells, confluent but non-polarized epithelial-like cells, dendritic cells, and human sperm. Representatives of the different families of commercially available surfactants – nonionic (Triton X-100 and monolaurin), zwitterionic (DDPS), anionic (SDS), and cationic (C(n)TAB (n = 10 to 16), C(12)PB, and C(12)BZK) – were examined. Triton X-100, monolaurin, DDPS and SDS were toxic to all cell types at concentrations around their critical micelle concentration (CMC) suggesting a non-selective mode of action involving cell membrane destabilization and/or destruction. All cationic surfactants were toxic at concentrations far below their CMC and showed significant differences in their toxicity toward polarized as compared with non-polarized cells. Their toxicity was also dependent on the chemical nature of the polar head group. Our results suggest an intracellular locus of action for cationic surfactants and show that their structure-activity relationships could be profitably exploited for STI prophylaxis in vaginal gel formulations. The therapeutic indices comparing polarized epithelial cell toxicity to sperm toxicity for all surfactants examined, except C(12)PB and C(12)BZK, does not justify their use as contraceptive agents. C(12)PB and C(12)BZK are shown to have a narrow therapeutic index recommending caution in their use in contraceptive formulations. CONCLUSIONS/SIGNIFICANCE: Our results contribute to understanding the mechanisms involved in surfactant toxicity, have a predictive value with regard to their safety, and may be used to design more effective and less harmful surfactants for use in topical applications for STI prophylaxis. Public Library of Science 2011-05-16 /pmc/articles/PMC3095630/ /pubmed/21603626 http://dx.doi.org/10.1371/journal.pone.0019850 Text en Inácio et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Inácio, Ângela S.
Mesquita, Katia A.
Baptista, Marta
Ramalho-Santos, João
Vaz, Winchil L. C.
Vieira, Otília V.
In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title_full In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title_fullStr In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title_full_unstemmed In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title_short In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception
title_sort in vitro surfactant structure-toxicity relationships: implications for surfactant use in sexually transmitted infection prophylaxis and contraception
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095630/
https://www.ncbi.nlm.nih.gov/pubmed/21603626
http://dx.doi.org/10.1371/journal.pone.0019850
work_keys_str_mv AT inacioangelas invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception
AT mesquitakatiaa invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception
AT baptistamarta invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception
AT ramalhosantosjoao invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception
AT vazwinchillc invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception
AT vieiraotiliav invitrosurfactantstructuretoxicityrelationshipsimplicationsforsurfactantuseinsexuallytransmittedinfectionprophylaxisandcontraception